Transoral Robotic Surgery for Residual and Recurrent Oropharyngeal Cancers.

gnorimies20.15 shared this article with you from Inoreader Transoral Robotic Surgery for Residual and Recurrent Oropharyngeal Cancers. Via pubmed: speech and language Related Articles Transoral Robotic Surgery for Residual and Recurrent Oropharyngeal Cancers. Otolaryngol Clin North Am. 2020 Dec;53(6):1091-1108 Authors: Paleri V, Hardman J, Brady G, George A, Kerawala C Abstract Transoral robotic surgery (TORS) is a well-established treatment option for treatment-naïve oropharyngeal cancer. For residual, recurrent, and new primary oropharyngeal tumors emerging in previously irradiated fields, the global experience of management with TORS is limited. This article discusses current concepts on this topic, offers a deeper insight into the transoral anatomy for these cases, and covers the specific complexities of resections in the various subsites of the oropharynx. It provides practical tips on reconstruction, recovery, and rehabilitation as well as offering a synthesis of the current evidence and exploring future trends. PMID: 33127041 [PubMed - as supplied by publisher] View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.